Jenna JEFFREY

Person

Oakland, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Azolopyrimidine for the treatment of cancer-related disorders
- Patent number 12,195,447
- Issue date Jan 14, 2025
- ARCUS BIOSCIENCES, INC.
- Joel Beatty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
- Patent number 12,103,907
- Issue date Oct 1, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid forms of an azolopyrimidine compound
- Patent number 11,993,584
- Issue date May 28, 2024
- ARCUS BIOSCIENCES, INC.
- Jenna Leigh Jeffrey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD73 inhibitors
- Patent number 11,931,343
- Issue date Mar 19, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Beatty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms of a CD73 inhibitor and the use thereof
- Patent number 11,819,512
- Issue date Nov 21, 2023
- ARCUS BIOSCIENCES, INC.
- Jenna Leigh Jeffrey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
- Patent number 11,787,762
- Issue date Oct 17, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
- Patent number 11,407,712
- Issue date Aug 9, 2022
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Azolopyrimidine for the treatment of cancer-related disorders
- Patent number 11,072,597
- Issue date Jul 27, 2021
- Joel Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azolopyrimidine for the treatment of cancer-related disorders
- Patent number 10,399,962
- Issue date Sep 3, 2019
- ARCUS BIOSCIENCES, INC.
- Joel Beatty
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
- Publication number 20240254079
- Publication date Aug 1, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
- Publication number 20230021476
- Publication date Jan 26, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS
- Publication number 20220144808
- Publication date May 12, 2022
- ARCUS BIOSCIENCES, INC.
- Joel BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF A CD73 INHIBITOR AND THE USE THEREOF
- Publication number 20220062313
- Publication date Mar 3, 2022
- ARCUS BIOSCIENCES, INC.
- Jenna Leigh JEFFREY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD73 INHIBITORS
- Publication number 20210346353
- Publication date Nov 11, 2021
- ARCUS BIOSCIENCES, INC.
- Joel BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
- Publication number 20210317079
- Publication date Oct 14, 2021
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF AN AZOLOPYRIMIDINE COMPOUND
- Publication number 20210269422
- Publication date Sep 2, 2021
- ARCUS BIOSCIENCES, INC.
- Jenna Leigh Jeffrey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS
- Publication number 20210101880
- Publication date Apr 8, 2021
- ARCUS BIOSCIENCES, INC.
- Joel BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PARENTERALLY ADMINISTERED IMMUNE ENHANCING DRUGS
- Publication number 20200405629
- Publication date Dec 31, 2020
- ARCUS BIOSCIENCES, INC.
- Juan Carlos JAEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS
- Publication number 20180215730
- Publication date Aug 2, 2018
- ARCUS BIOSCIENCES, INC.
- Joel BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jenna JEFFREY

Person

Patents Grantslast 30 patents

Azolopyrimidine for the treatment of cancer-related disorders

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

Solid forms of an azolopyrimidine compound

CD73 inhibitors

Solid forms of a CD73 inhibitor and the use thereof

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α

Azolopyrimidine for the treatment of cancer-related disorders

Azolopyrimidine for the treatment of cancer-related disorders

Patents Applicationslast 30 patents

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS

SOLID FORMS OF A CD73 INHIBITOR AND THE USE THEREOF

CD73 INHIBITORS

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

SOLID FORMS OF AN AZOLOPYRIMIDINE COMPOUND

AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS

PARENTERALLY ADMINISTERED IMMUNE ENHANCING DRUGS

AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS